Non-alcoholic fatty liver (NAFLD) is the most common liver disease worldwide, progressing
from simple steatosis to necroinflammation and fibrosis (leading to non-alcoholic …

Adverse fluctuations in the distribution of the intestinal microbiome cohort has been
associated with the onset of intra-and extra-intestinal inflammatory conditions, like the …

Gut microbiota is involved in obesity, metabolic syndrome and the progression of
nonalcoholic fatty liver disease (NAFLD). It has been recently suggested that the flavonoid …

Gut-derived bacterial lipopolysaccharide (LPS) and subsequent hepatic toll-like receptor 4
(TLR4) activation have been recognized to be involved in the onset of diet-induced …

The gut microbiota plays critical roles in development of obese-related metabolic diseases
such as nonalcoholic fatty liver disease (NAFLD), type 2 diabetes (T2D), and insulin …

We investigated the gut microbiota in patients with non-alcoholic fatty liver disease (NAFLD)
and its correlation with fibrosis and steatosis stratified by body mass index, as reflected in …

The present study investigated the mechanism underlying the impact of hesperidin (HES) on
nonalcoholic fatty liver (NAFLD). C57BL/6J male mice were administered a low-fat diet, high …

Crohn's disease (CD) is a chronic inflammatory disease of the gastrointestinal tract (GIT).
Cigarette smoke (CS) exposure and chronic obstructive pulmonary disease (COPD) are risk …

The determination of a causal association between gut microbiota and a range of
dyslipidemia remains uncertain. To clarify these associations, we employed a two-sample …

Human microbiota are distinct communities of microorganisms that resides at different body
niches. Exploration of the human microbiome has become a reality due to the availability of …